Study #2016-0650
Reducing Blood Loss in Hemipelvectomy Surgery with the use Tranexamic Acid (TXA)
MD Anderson Study Status
Enrolling
Treatment Agent
Tranexamic Acid
Description
This early phase I trial studies how well tranexamic acid works in reducing the loss of blood in patients with pelvic tumors undergoing hemipelvectomy surgery. Tranexamic acid decreases blood loss by stabilizing clots and preventing clot lysis in patients undergoing surgery.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Pelvic Mass
Study phase:
Phase I (Early)
Physician name:
Valerae Lewis
Department:
Orthopaedic Oncology
For general questions about clinical trials:
1-844-317-6206
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.